Umbilical Cord‐Mesenchymal Stromal Cell‐Derived Extracellular Vesicles Target the Liver to Improve Neurovascular Health in Type 2 Diabetes With Non‐Alcoholic Fatty Liver Disease

Documenti analoghi

• First‐In‐Human Application of Human Umbilical Cord‐Derived Extracellular Vesicles in Tethered Spinal Cord Release Surgery
  di: Matthias Krause, et al.
  Pubblicazione: (2025)
• Effects of Hydrogels on Mesenchymal Stem/Stromal Cells Paracrine Activity and Extracellular Vesicles Production
  di: Oscar Fabian Garcia‐Aponte, et al.
  Pubblicazione: (2025)
• IFN‐γ‐Induced CD317 Tethers Extracellular Vesicles to Mesenchymal Stromal Cells Interfering With Immune Modulation
  di: Anton Selich, et al.
  Pubblicazione: (2025)
• The Small Molecule H89 Facilitates Mesenchymal Stem Cell‐derived Extracellular Vesicle Release and Optimizes Therapeutic Efficacy in Liver Regeneration
  di: Yu Fu, et al.
  Pubblicazione: (2026)
• Circulating Liver‐Derived and CD36 + Extracellular Vesicles Correlate With Ectopic Liver Fat and Markers of Fibrosis in Metabolic Dysfunction‐Associated Steatotic Liver Disease and Decrease During Weight Loss Intervention
  di: Maiken Mellergaard, et al.
  Pubblicazione: (2026)